-- 周一,主要生物燃料原料期货价格涨跌互现。尽管原油价格走高,芝加哥大豆期货价格上涨,而芝加哥豆油和马来西亚棕榈油期货价格却下跌。 芝加哥期货交易所5月大豆期货合约连续第二个交易日上涨,涨幅0.19%,至每蒲式耳11.66美元。5月豆油期货合约下跌0.21%,至每磅71.76美分。 由于美伊和谈前景不明朗,豆油价格走势与原油价格走势背离。 与此同时,预计本周美国部分地区将有降雨,这可能会延缓大豆播种,从而提振了大豆价格。 然而,全球供应增加,尤其是巴西创纪录的大豆收割工作即将完成,对整个大豆市场构成压力。 据价格报告机构MySteel称,“南美洲大豆丰收的基本前景依然不变,全球大豆供应预计将保持宽松,短期内缺乏推动市场上涨的关键利好因素。” MySteel表示,“总体而言,美国大豆价格正处于强劲的压榨需求和来自南美洲的供应压力之间的平衡状态,呈现出区间震荡的走势,既有上涨压力,也有下跌支撑。” 咨询公司Water Street Solutions的Darren Frye告诉Ag Web,区间震荡的价格走势和图表阻力将阻止7月大豆期货价格突破每蒲式耳11.80美元。 ADM Investor Services的Mark Soderberg表示,展望未来,市场预计将把注意力转向5月中旬的中美峰会,交易员们将等待中国方面释放出更多需求的信号。 周一,受出口疲软和马来西亚林吉特兑美元汇率上涨0.36%的影响,马来西亚棕榈油期货价格下跌超过1%,与原油价格走势脱钩。 马来西亚衍生品交易所5月和6月交割的原棕榈油合约分别收于每吨4465马来西亚林吉特(1129.38美元)和4505林吉特。 据Trading Economics援引货运调查机构的数据,马来西亚4月1日至25日期间的棕榈油出货量较上月下降15.7%。 此前,马来西亚棕榈油理事会表示,由于买家预期运输成本将大幅上涨而提前采购,以及印尼竞争对手因出口税上涨而导致出货量下降,第一季度出口量同比增长29.1%。 印尼自7月1日起将棕榈油生物柴油掺混比例从40%提高到50%,此举或将提振马来西亚未来的棕榈油出口。 马来西亚棕榈油委员会(MPOC)表示,印尼的B50计划每年可额外吸收300万吨棕榈油。 泰国将生物柴油掺混比例从B5提高到B7,预计该国年消费量将增加35万吨;马来西亚政府将生物柴油掺混比例从B10提高到B15,预计该国需求量将增加30万吨。 生物燃料需求的增长、原油价格的上涨以及厄尔尼诺现象可能带来的供应风险,都将支撑棕榈油价格。马来西亚棕榈油委员会预测,短期内棕榈油价格将维持在每吨4500林吉特左右。 马来西亚棕榈油委员会(MPOC)表示:“然而,由于主要进口国通胀疲软和经济增长放缓,出口需求下降,加之棕榈油产量逐步进入季节性高峰,库存上升,棕榈油价格的进一步上涨可能受到限制。” 据马来西亚国家通讯社(Bernama)援引Interband集团高级棕榈油交易员Jim Teh的话称,受获利回吐影响,本周棕榈油价格可能在每吨4200至4300令吉之间波动。 在美国,纽约商品交易所(NYMEX)5月交割的乙醇期货价格周五上涨1.95%,至每加仑约1.96美元。
Related Articles
Top Midday Gainers
Sagimet Biosciences (SGMT) said Monday it has priced an underwritten offering of about 29.2 million shares at $6.00 each to raise about $175 million to help fund its clinical trial.Shares soared 43% as intraday trading volume catapulted to over 45.2 million from a daily average of about 516,000.Veradermics (MANE) said Monday part A of its phase 2/3 trial of VDPHL01 oral pill in males with mild-to-moderate pattern hair loss met all primary and all key secondary endpoints with "high" statistical significance.Shares surged 32%, with intraday trading volume of over 2.5 million from a daily average of roughly 446,000.Oruka Therapeutics (ORKA) jumped 16% after the company said Monday almost 64% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.More than 5.10 million shares traded intraday, compared with a daily average of about 760,000.Price: $8.36, Change: $+2.50, Percent Change: +42.58%
Sector Update: Financial Stocks Rise Monday Afternoon
Financial stocks were advancing in Monday afternoon trading, with the NYSE Financial Index increasing 0.4% and the State Street Financial Select Sector SPDR ETF (XLF) adding 0.7%.The Philadelphia Housing Index rose 0.4%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) was decreasing 0.6%.Bitcoin (BTC-USD) was falling 2.4% to $76,783, and the yield for 10-year US Treasuries was rising 3.2 basis points to 4.34%.In corporate news, Citigroup (C) plans to strengthen its investment banking divisions in Japan and China by recruiting upper-level executives to capture additional buyout opportunities, Reuters reported, citing the firm's regional division head, Kaustubh Kulkarni. Citi shares added 0.4%.Goldman Sachs' (GS) Goldman Sachs Alternatives participated as the lead investor in Kashable's $60 million Series C funding round, Kashable said Monday. Goldman Sachs Alternatives participated with up to $50 million, which includes an initial $25 million investment and $25 million to be funded in coming months, subject to conditions, Kashable said. Goldman shares added 0.6%.Oppenheimer (OPY) shares rose 4% after the company said its Oppenheimer & Co. unit agreed to pay $70 million to settle a class-action lawsuit tied to its cash sweep program, avoiding a trial where damages could have exceeded $440 million.
Update: Gold Lower Even as the Dollar Falls Ahead of This Week's U.S. Interest Rate Decision
(Updates prices.)Gold prices were down midafternoon Monday, remaining rangebound even as the dollar fell ahead of the Wednesday interest-rate announcement from the Federal Reserve.Gold for June delivery was last seen down US$42.60 to US$4,698.30 per ounce, remaining within the US$200 range it has been stuck in since the start of the war on Iran, as high oil prices raise concerns over higher inflation and threaten to boost interest rates.The Federal Open Market Committee (FOMC) will make its latest interest-rate decision at the Wednesday afternoon end to its two-day meeting. The CME FedWatch Tool sees a 100% probability the group will leave rates unchanged."Gold remains stuck in neutral within a broad USD 200 range around USD 4,750, with most intraday price action dictated by energy prices and the ebb and flow of headlines from the White House and the Middle East. The FOMC is widely expected to leave rates unchanged on Wednesday," Saxo Bank noted.The dollar was lower, with the ICE dollar index last seen down 0.09 points to 98.44. Treasury yields rose, with the yield on the two-year note up 2.1 basis points to 3.812%, while the 10-year note was paying 4.342%, up 3.5 points.